Visiting Scientist
Daeseong Kim, MD
First author of the lab’s inaugural biliary tract cancer study, identifying PI3K-pathway activation as a molecular determinant of chemotherapy benefit in advanced BTC (Clinical and Molecular Hepatology, 2026).
Education & Honors
Education
- MD, Yonsei University College of Medicine
Awards and Honors
- Dean’s Award - Summa Cum Laude for Innovation, Yonsei University College of Medicine (2025)
- Severance Award - Innovation, Severance Hospital (2023)
- Severance Award - Leadership, Severance Hospital (2021)